Table 2. Phenotypic Analysis of the... | American Society of Hematology

Table 2.

Phenotypic Analysis of the Selected Patients

Patients	CD2⁺	CD5⁺	CD16⁺	CD20⁺	CD25⁺	CD56⁺	HLA-DR⁺	TCRAB⁺	TCRGD⁺	CD4⁺CD45RA⁺	CD4⁺CD45RO⁺	CD8⁺CD45RA⁺	CD8⁺CD45RO⁺	CD4⁺CD25⁺	CD8⁺CD25⁺	CD4⁺HLA-DR⁺	CD8⁺HLA-DR⁺
ROPI	87.1	85.9	8.8	4.8	1.6	11.0	9.3	75.7	2.9	13.2	41.0	10.8	6.9	1.2	0.1	1.7	1.4
GEGU	82.6	93.2	11.5	3.1	3.7	15.7	7.4	71.9	0.5	24.4	29.6	21.5	7.8	1.9	0.9	1.9	3.7
LOME	89.9	79.5	3.4	3.0	1.5	0.6	9.8	79.2	3.4	16.6	26.7	26.4	11.4	0.0	0.2	3.5	4.7
MAGHI	75.9	59.8	15.8	9.0	0.1	5.4	9.3	48.1	3.3	29.7	23.5	16.3	3.6	0.0	0.0	2.4	1.0
Controls	80 ± 6	78 ± 7	15 ± 7	8 ± 5	<2	14 ± 5	12 ± 3	74 ± 8	<2	19 ± 8	29 ± 10	18 ± 9	8 ± 3	<5	ND	<4	ND

Patients	CD2⁺	CD5⁺	CD16⁺	CD20⁺	CD25⁺	CD56⁺	HLA-DR⁺	TCRAB⁺	TCRGD⁺	CD4⁺CD45RA⁺	CD4⁺CD45RO⁺	CD8⁺CD45RA⁺	CD8⁺CD45RO⁺	CD4⁺CD25⁺	CD8⁺CD25⁺	CD4⁺HLA-DR⁺	CD8⁺HLA-DR⁺
ROPI	87.1	85.9	8.8	4.8	1.6	11.0	9.3	75.7	2.9	13.2	41.0	10.8	6.9	1.2	0.1	1.7	1.4
GEGU	82.6	93.2	11.5	3.1	3.7	15.7	7.4	71.9	0.5	24.4	29.6	21.5	7.8	1.9	0.9	1.9	3.7
LOME	89.9	79.5	3.4	3.0	1.5	0.6	9.8	79.2	3.4	16.6	26.7	26.4	11.4	0.0	0.2	3.5	4.7
MAGHI	75.9	59.8	15.8	9.0	0.1	5.4	9.3	48.1	3.3	29.7	23.5	16.3	3.6	0.0	0.0	2.4	1.0
Controls	80 ± 6	78 ± 7	15 ± 7	8 ± 5	<2	14 ± 5	12 ± 3	74 ± 8	<2	19 ± 8	29 ± 10	18 ± 9	8 ± 3	<5	ND	<4	ND

Values are percentages.

Abbreviation: ND, not done.